Home / Drugs / dimethyl fumarate kit

dimethyl fumarate kit

FDA Drug Profile — DIMETHYL FUMARATE

Drug Details

Generic Name
dimethyl fumarate kit
Brand Names
DIMETHYL FUMARATE
Application Number
ANDA210309
Sponsor
Glenmark Pharmaceuticals Inc., USA
NDC Codes
1
Dosage Forms
KIT
Routes
N/A
Active Ingredients
N/A

Indications and Usage

1 INDICATIONS AND USAGE Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Dimethyl fumarate delayed-release capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )